Paul Thomas

Paul Thomas has an estimated net worth of $40.9 Million. This is based on reported shares across multiple companies, which include ABIOMED INC, Axogen, Inc., Roka BioScience, Inc., SURGALIGN HOLDINGS, INC., KINETIC CONCEPTS INC /TX/, RTI SURGICAL, INC., AVANIR PHARMACEUTICALS, Aegerion Pharmaceuticals, Inc., ORTHOVITA INC, and LIFECELL CORP.

2005 was Paul Thomas's most active year for acquiring shares with 25 total transactions. Paul Thomas's most active month to acquire stocks was the month of December. 2005 was Paul Thomas's most active year for disposing of shares, totalling 36 transactions. Paul Thomas's most active month to dispose stocks was the month of July. 2005 saw Paul Thomas paying a total of $2,446,968.92 for 956,352 shares, this is the most they've acquired in one year. In 2008 Paul Thomas cashed out on 612,907 shares for a total of $17,567,070.33, their largest year based on trade value.